Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events – case report

A switch to iptacopan may be an option for pegcetacoplan treated patients who experience repeated BTH in spite of dose escalation.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2025-09-20
DOI
https://doi.org/10.1080/16078454.2025.2559333
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events – case report

Andreas Reinisch, Wolfgang Füreder
Hematology
Hemoglobinopathies and Related Disorders
article

Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events – case report

Andreas Reinisch, Wolfgang Füreder
article en

Abstract

A switch to iptacopan may be an option for pegcetacoplan treated patients who experience repeated BTH in spite of dose escalation.

HematologyVol. 30(1)
Medical University of Graz (AT), Medical University of Vienna (AT)
Openalex Percentile: Top 65%
Hemoglobinopathies and Related Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events – case report — Andreas Reinisch, Wolfgang Füreder · Hematology (2025) | TGRS Research Map | TGRS